Pharmacokinetics of ofloxacin after parenteral and oral administration - Wikidata - awgldk - TriplyDB

Pharmacokinetics of ofloxacin after parenteral and oral administration

Pharmacokinetics of ofloxacin after parenteral and oral administration

http://www.wikidata.org/entity/Q35541436

about

Pharmacokinetics of temafloxacin in humans after multiple oral doses Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters.Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials.Bioequivalence of oral and intravenous ofloxacin after multiple-dose administration to healthy male volunteers.Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process.Pharmacodynamic modeling of the in vivo interaction between cefotaxime and ofloxacin by using serum ultrafiltrate inhibitory titers.Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis Pharmacokinetics of FCE 22891, a new oral penem.Pharmacokinetics of lomefloxacin in renally compromised patients Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.Concentrations of ofloxacin in serum and cerebrospinal fluid of patients without meningitis receiving the drug intravenously and orally Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis.Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant tuberculosis Pharmacokinetics of temafloxacin in humans after single oral doses.Effects of two cations on gastrointestinal absorption of ofloxacin.High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections.Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.Pharmacokinetics of quinolones: newer aspects.Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients.Clinical pharmacokinetics and pharmacodynamics of tigecycline.Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children.Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transporters.Pharmacokinetics of ciprofloxacin with reference to other fluorinated quinolones.Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.Synergistic effect of ofloxacin and magnesium deficiency on joint cartilage in immature rats.Effect of inflammation on intraocular penetration of intravenous ofloxacin in albino rabbits Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm.Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin.Effect of renal impairment on distribution of ofloxacin.Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers.

P2860

Q24679273-7B8D094A-3E0B-495A-BC08-5C981E1AE723 Q33895157-BD993E6B-9FA4-48E1-B92C-DF61D66D8AC7 Q34098582-2DC1487D-BF87-4FD6-AC24-1D09B77F6442 Q34353841-0C127D12-43DB-48AC-B5DC-71B8C595278A Q35118336-3C787300-05AD-4BF7-8F62-4C66232803F0 Q35126874-3896762B-61AF-4C79-909E-2762A2343E9F Q35136125-7B32DD73-94B4-44BC-BD06-BE334A806D91 Q35245010-E306D7E9-B1D0-4AC1-BEFD-8B5539B20984 Q35245897-1C39CF91-217B-4DE3-9E77-42ADE7CD0E0E Q35248574-6F994129-4D06-4183-9121-F6E2468994A1 Q35258286-9C4E484A-96A3-4EBF-BF53-F15D1C62FFE1 Q35285274-CE07F59E-6F1C-4365-AFE4-3AF1B4124E21 Q35285981-25D9E613-17AF-4655-9A5C-D5669003AA85 Q35346446-EF82C3A7-4EB7-4D99-A884-8806DA1222FD Q35353895-B32EA397-09BD-4217-83F9-EF3AA8549022 Q35564524-C987080F-FE02-4CB8-A58D-57D737381929 Q35564579-20A9B49B-0673-4338-8D56-8FDB77E80742 Q35820813-B5995191-FF11-40E9-9792-570874E1CC38 Q36075800-CCEF7C30-1E15-4704-9D77-592915AD8FFC Q36086373-8B77B83F-8648-4E3C-9ECD-815CC9D329F2 Q36753040-E4E7EE25-EC5B-476F-91A4-34D43677BF20 Q36755927-D8F28A8E-CEEC-4480-B4F7-6F490A46308A Q36757484-389D0FA7-2988-421B-8092-4CB32DB32608 Q37008814-68A67DF9-3E96-46F1-8DEF-B315798DABE2 Q37130693-B51144E4-7E17-42BC-86A9-3FF0ADFCF47E Q37167024-53568B92-C29C-478C-9626-EB45A4389839 Q37222580-9000A2D9-1193-4328-BDBC-C6A326EC2D2F Q37544479-FEB22DB1-F68A-4EE3-855F-8E343A8B38AF Q37590845-316872BC-A5F3-4C98-A009-89FCCD893DED Q37712966-71F5A4A7-10F8-4F1C-9A9A-2641BDEF9C41 Q37995676-F7E3CE04-3FE7-46F0-8029-005C04EE073D Q38271416-DD23235C-27C3-4095-9511-D0FD7DEAE821 Q39557763-83ADB8BE-1C53-42BF-9F19-72FC257B935F Q39651999-22B83D84-B07D-406B-956D-A55384B99441 Q39779239-E2AD9475-13E5-4F5D-B32E-345B62F52247 Q39779662-D68B5DEC-885C-46AB-93A9-7937C527CEDE Q39780493-40075484-4197-47D3-99F3-838349578193 Q39815532-A0A64542-6B55-4BFA-A7EA-919441737F6D Q39832467-AA330B05-FD47-456B-953A-6DE3B4231365 Q39867874-61F44276-5A3E-4AE2-99D7-00F8BB0783E1

P2860

Pharmacokinetics of ofloxacin after parenteral and oral administration

http://www.wikidata.org/entity/Q35541436

description

1987 nî lūn-bûn

@nan

1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Pharmacokinetics of ofloxacin after parenteral and oral administration

@ast

Pharmacokinetics of ofloxacin after parenteral and oral administration

@en

type

label

Pharmacokinetics of ofloxacin after parenteral and oral administration

@ast

Pharmacokinetics of ofloxacin after parenteral and oral administration

@en

prefLabel

Pharmacokinetics of ofloxacin after parenteral and oral administration

@ast

Pharmacokinetics of ofloxacin after parenteral and oral administration

@en

P1433

Q35541436-742A73A3-8D1E-4A8D-997B-B433E31BD6B4

P1476

Q35541436-271CDE41-4B5E-46C4-A824-896A1BA76E3F

P2093

Q35541436-09E9A89E-3258-4DB8-B432-67CF98E03B3F

Q35541436-3B6D3B79-D0AC-4706-927D-B87A925846E7

Q35541436-8F11E71C-9350-4056-BA8A-872A9CC169D0

Q35541436-98CC917F-D4D6-45D7-8A5E-E09AE120D37A

Q35541436-C423D343-072A-4454-AA0F-83C13C0696F5

Q35541436-CC77674C-26D5-42AE-ADF4-F4F6952C6555

Q35541436-DA2BE42C-5F2A-4443-88FE-039A308A007E

P2860

Q35541436-07A06C95-3F24-4E32-A3BC-473CDAFB6DF5

Q35541436-14E74558-BCDB-429D-8011-FF12F5914C12

Q35541436-181B5FD7-DBF1-40C7-8A2C-0B4046BD9100

Q35541436-193AF9A1-0E82-46F8-84DE-6FBCCB18351F

Q35541436-20DA7BB8-D866-41E2-BF39-55C250D47A5B

Q35541436-2120483E-31F0-4635-9CC1-E1579A82A291

Q35541436-2233BFFF-0CCE-43C8-8748-6A3BE4B707F8

Q35541436-3EE7E78D-FF8F-4D58-8BB4-CBDE9ED8DD58

Q35541436-473E278D-0D75-4F62-8FD9-91226AF5DD00

Q35541436-6D724B2F-931C-4338-BC29-67CFE48DCEE0

P304

Q35541436-F670712D-07E2-45B6-AC8F-AA6BABD808D0

P31

Q35541436-872EB22A-99AE-48D3-B9D5-A9E34B826B78

P356

Q35541436-32257078-90F5-4FFA-8ED5-8F82CEA26728

P407

Q35541436-848214E0-AD3A-4BD4-939B-F32437525FB2

P433

Q35541436-05A359A8-5427-4E68-8535-677486CA6646

P478

Q35541436-C87791CD-E479-456B-BAE6-C61C0293938E

P577

Q35541436-66B36DB2-0419-4961-B90A-B480D0D59609

P698

Q35541436-DB850A56-4A9C-4DC3-B04A-30A885368F33

P932

Q35541436-B4520BE4-2D7C-44E4-B74E-D343B81083F8

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacokinetics of ofloxacin after parenteral and oral administration

@en

P2093

Borner K

http://www.w3.org/2001/XMLSchema#string

Höffken G

http://www.w3.org/2001/XMLSchema#string

Kirch A

http://www.w3.org/2001/XMLSchema#string

Koeppe P

http://www.w3.org/2001/XMLSchema#string

Lode H

http://www.w3.org/2001/XMLSchema#string

Olschewski P

http://www.w3.org/2001/XMLSchema#string

Sievers B

http://www.w3.org/2001/XMLSchema#string

P2860

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

Clinical pharmacokinetics (second of two parts).

Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.

Pharmacokinetics of ciprofloxacin after oral and parenteral administration.

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence

Comparative pharmacokinetics of apalcillin and piperacillin.

Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.

Dose ranging study and constant infusion evaluation of ciprofloxacin.

P304

1338-1342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.31.9.1338

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

1987-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3479046

http://www.w3.org/2001/XMLSchema#string

P932

174938

http://www.w3.org/2001/XMLSchema#string